Kalaris Therapeutics, Inc. (KLRS) stock
KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.37−0.06 (-4.20%)
Close on Nov 18, 2026Market cap $32.61MP/E –Yield –
Kalaris Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Kalaris Therapeutics's profit margin for the twelve months ending Dec 31, 2019 was -14447.9%. For fiscal 2019 it was -14447.9%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -14447.9% | – |
See a number that looks wrong?